Richard L. Love
2017
In 2017, Richard L. Love earned a total compensation of $118.1K as Former Interim Chief Executive Officer and President at CTI BioPharma, a 69% decrease compared to previous year.
Compensation breakdown
| Salary | $93,461 |
|---|---|
| Other | $24,627 |
| Total | $118,088 |
Love received $93.5K in salary, accounting for 79% of the total pay in 2017.
Love also received $24.6K in other compensation.
Rankings
In 2017, Richard L. Love's compensation ranked 14,391st out of 14,666 executives tracked by ExecPay. In other words, Love earned more than 1.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,391 out of 14,666 | 2nd |
Division Manufacturing | 5,659 out of 5,768 | 2nd |
Major group Chemicals And Allied Products | 2,031 out of 2,074 | 2nd |
Industry group Drugs | 1,688 out of 1,730 | 2nd |
Industry Pharmaceutical Preparations | 1,296 out of 1,329 | 3rd |
Source: SEC filing on March 30, 2018.
Love's colleagues
We found six more compensation records of executives who worked with Richard L. Love at CTI BioPharma in 2017.
2017
Adam Craig
CTI BioPharma
Chief Executive Officer
2017
Bruce Seeley
CTI BioPharma
Chief Operating Officer
2017
Jack Singer
CTI BioPharma
Chief Scientific Officer
2017
David Kirske
CTI BioPharma
Chief Financial Officer
2017
Louis Bianco
CTI BioPharma
Former Executive Vice President, Finance and Administration
2017
Matthew Plunkett
CTI BioPharma